T1	CHEM 59 66	fármaco
#1	AnnotatorNotes T1	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T2	PROC 1537 1564	escala de Rankin modificada
#2	AnnotatorNotes T2	C3888574; Modified Rankin score; Diagnostic Procedure
T3	DISO 83 107	hemorragia intracerebral
#3	AnnotatorNotes T3	C2937358; Cerebral Hemorrhage; Pathologic Function
T4	CHEM 131 148	Ácido tranexámico
#4	AnnotatorNotes T4	C0040613; tranexamic acid; Organic Chemical · Pharmacologic Substance
T5	DISO 155 179	hemorragia intracerebral
#5	AnnotatorNotes T5	C2937358; Cerebral Hemorrhage; Pathologic Function
T6	DISO 227 243	Derrame cerebral
#6	AnnotatorNotes T6	C0038454; Cerebrovascular accident; Disease or Syndrome
T7	DISO 270 294	Hemorragia intracerebral
#7	AnnotatorNotes T7	C2937358; Cerebral Hemorrhage; Pathologic Function
T8	ANAT 817 830	arteriovenosa
T9	DISO 443 478	accidente hemorrágico intracerebral
T10	DISO 519 554	accidente hemorrágico intracerebral
T11	DISO 677 701	hemorragia intracerebral
#8	AnnotatorNotes T11	C2937358; Cerebral Hemorrhage; Pathologic Function
T12	PROC 715 741	tratamiento anticoagulante
#9	AnnotatorNotes T12	C0150457; Anticoagulant therapy; Therapeutic or Preventive Procedure
T13	DISO 757 777	anomalía estructural
T14	PROC 743 754	trombolisis
T15	DISO 804 830	malformación arteriovenosa
T16	DISO 832 841	aneurisma
#10	AnnotatorNotes T16	C0002940; Aneurysm; Pathologic Function
T17	DISO 843 848	tumor
#11	AnnotatorNotes T17	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C0577559; Mass of body structure; Finding
T18	DISO 850 866	trombosis venosa
#12	AnnotatorNotes T18	C0042487; Venous Thrombosis; Pathologic Function
T19	DISO 917 923	lesión
#13	AnnotatorNotes T19	C0221198; Lesion; Finding
T20	DISO 1075 1092	sangrado cerebral
#14	AnnotatorNotes T20	C2937358; Cerebral Hemorrhage; Pathologic Function
T21	CHEM 1166 1183	ácido tranexámico
#15	AnnotatorNotes T21	C0040613; tranexamic acid; Organic Chemical · Pharmacologic Substance
T22	PROC 1241 1252	seguimiento
#16	AnnotatorNotes T22	C1522577; Follow up; Health Care Activity | C0420316; Other follow-up; Health Care Activity
T23	PROC 1323 1337	ensayo clínico
#17	AnnotatorNotes T23	C0008976; Clinical Trials; Research Activity
T24	PROC 1372 1393	prevención secundaria
#18	AnnotatorNotes T24	C0679699; Secondary Prevention; Therapeutic or Preventive Procedure
T25	DISO 1643 1666	enfermedad concomitante
T26	DISO 1680 1698	cáncer metastásico
T27	ANAT 235 243	cerebral
#19	AnnotatorNotes T27	C0242202; Cerebrum; Body Part, Organ, or Organ Component | C1269537; Entire brain; Body Part, Organ, or Organ Component | C1280654; Entire cerebrum; Body Part, Organ, or Organ Component
T28	CHEM 727 741	anticoagulante
#20	AnnotatorNotes T28	C0003280; Anticoagulants; Pharmacologic Substance
T29	ANAT 860 866	venosa
#21	AnnotatorNotes T29	C0042449; Veins; Body Part, Organ, or Organ Component | C1278960; Entire vein; Body Part, Organ, or Organ Component
T30	ANAT 1084 1092	cerebral
#22	AnnotatorNotes T30	C0242202; Cerebrum; Body Part, Organ, or Organ Component | C1269537; Entire brain; Body Part, Organ, or Organ Component | C1280654; Entire cerebrum; Body Part, Organ, or Organ Component
T31	DISO 1510 1522	Discapacidad
#23	AnnotatorNotes T31	C0231170; Disability; Finding
T32	PROC 1570 1595	escala de coma de Glasgow
#24	AnnotatorNotes T32	C0278349; Glasgow coma testing and evaluation; Laboratory Procedure
T33	Date 13 17	2012
T34	LIVB 336 343	Adultos
#25	AnnotatorNotes T34	C0001675; Adult; Age Group
T35	LIVB 379 388	pacientes
#26	AnnotatorNotes T35	C0030705; Patients; Patient or Disabled Group
T36	Duration 410 430	sus primeras 8 horas
T37	LIVB 663 672	Pacientes
#27	AnnotatorNotes T37	C0030705; Patients; Patient or Disabled Group
T38	LIVB 940 949	pacientes
#28	AnnotatorNotes T38	C0030705; Patients; Patient or Disabled Group
T40	LIVB 1096 1104	paciente
#29	AnnotatorNotes T40	C0030705; Patients; Patient or Disabled Group
T42	Neg_cue 1230 1237	impidan
T43	LIVB 1260 1269	pacientes
#30	AnnotatorNotes T43	C0030705; Patients; Patient or Disabled Group
T44	Duration 1272 1283	los 90 días
T45	Neg_cue 1339 1344	salvo
T47	Duration 1497 1504	21 días
T39	Duration 1620 1628	<3 meses
T41	LIVB 1407 1420	participantes
#31	AnnotatorNotes T41	C4554048; Study Participant; Population Group
T46	PROC 976 986	reclutados
#32	AnnotatorNotes T46	C0242800; Patient Recruitment; Research Activity
T48	PROC 1451 1461	reclutarse
#33	AnnotatorNotes T48	C0242800; Patient Recruitment; Research Activity
A1	Assertion T22 Negated
A2	Assertion T24 Negated
A3	Status T13 History_of
A4	Status T15 History_of
A5	Status T16 History_of
A6	Status T17 History_of
A7	Status T18 History_of
A8	Status T21 History_of
A9	Status T31 History_of
#34	AnnotatorNotes T10	C5392098; Intracerebral Hemorrhagic Stroke; Disease or Syndrome 
#35	AnnotatorNotes T9	C5392098; Intracerebral Hemorrhagic Stroke; Disease or Syndrome 
#36	AnnotatorNotes T13	C0749075; STRUCTURAL ANOMALY; Finding
#37	AnnotatorNotes T25	C0243087; concomitant disease; Pathologic Function 
#38	AnnotatorNotes T26	C0027627; Neoplasm Metastasis; Neoplastic Process 
R1	Negation Arg1:T45 Arg2:T24	
T49	CONC 508 514	inicio
A10	Assertion T49 Speculated
#39	AnnotatorNotes T49	C0439659; Beginning; Temporal Concept
T50	Spec_cue 559 570	desconocido
R2	Speculation Arg1:T50 Arg2:T49	
R3	Overlap Arg1:T10 Arg2:T49	
T51	Spec_cue 956 971	susceptibles de
A11	Assertion T46 Speculated
R4	Speculation Arg1:T51 Arg2:T46	
T52	Observation 1110 1130	retirado del estudio
#40	AnnotatorNotes T52	C0422727; Patient withdrawn from trial; Finding (?)
R7	Negation Arg1:T42 Arg2:T22	
T54	Quantifier_or_Qualifier 180 188	primaria
#42	AnnotatorNotes T54	C0205225; Primary; Qualitative Concept
R9	Has_Quantifier_or_Qualifier Arg1:T5 Arg2:T54	
T55	Quantifier_or_Qualifier 189 194	aguda
#43	AnnotatorNotes T55	C0439557; Acut phase; Temporal Concept
R10	Has_Quantifier_or_Qualifier Arg1:T5 Arg2:T55	
R11	Location_of Arg1:T27 Arg2:T6	
T56	Quantifier_or_Qualifier 304 309	aguda
#44	AnnotatorNotes T56	C0439557; Acut phase; Temporal Concept
R12	Has_Quantifier_or_Qualifier Arg1:T7 Arg2:T56	
T57	Quantifier_or_Qualifier 479 484	agudo
#45	AnnotatorNotes T57	C0439557; Acut phase; Temporal Concept
R13	Has_Quantifier_or_Qualifier Arg1:T9 Arg2:T57	
T58	Quantifier_or_Qualifier 295 303	primaria
#46	AnnotatorNotes T58	C0205225; Primary; Qualitative Concept
R14	Has_Quantifier_or_Qualifier Arg1:T7 Arg2:T58	
R15	Experiences Arg1:T35 Arg2:T9	
R16	Experiences Arg1:T34 Arg2:T9	
R17	Has_Duration_or_Interval Arg1:T9 Arg2:T36	
T59	Quantifier_or_Qualifier 485 495	espontáneo
#47	AnnotatorNotes T59	C0205359; Spontaneous; Functional Concept
R18	Has_Quantifier_or_Qualifier Arg1:T9 Arg2:T59	
R19	Experiences Arg1:T37 Arg2:T11	
R20	Experiences Arg1:T37 Arg2:T12	
R21	Used_for Arg1:T28 Arg2:T12	
R22	Location_of Arg1:T29 Arg2:T18	
R23	Location_of Arg1:T8 Arg2:T15	
#48	AnnotatorNotes T8	C0450109; Arteriovenous; Spatial Concept 
R24	Causes Arg1:T12 Arg2:T11	
R25	Causes Arg1:T14 Arg2:T11	
R26	Causes Arg1:T13 Arg2:T11	
R27	Causes Arg1:T15 Arg2:T11	
#49	AnnotatorNotes T15	C0917804; Arteriovenous Malformations, Cerebral; Congenital Abnormality (?)
R28	Causes Arg1:T16 Arg2:T11	
R29	Causes Arg1:T17 Arg2:T11	
R30	Causes Arg1:T18 Arg2:T11	
R31	Experiences Arg1:T37 Arg2:T14	
R32	Experiences Arg1:T37 Arg2:T13	
R33	Experiences Arg1:T37 Arg2:T15	
R34	Experiences Arg1:T37 Arg2:T16	
R35	Experiences Arg1:T37 Arg2:T17	
R36	Experiences Arg1:T37 Arg2:T18	
R5	Before Arg1:T46 Arg2:T72	
R37	Experiences Arg1:T38 Arg2:T19	
R38	Location_of Arg1:T30 Arg2:T20	
T60	Observation 1010 1047	se conozca la existencia de una causa
R39	Before Arg1:T60 Arg2:T52	
R40	Experiences Arg1:T40 Arg2:T20	
T61	CONC 1189 1209	Factores geográficos
#50	AnnotatorNotes T61	C0017444; Geographic Factors; Conceptual Entity
R42	After Arg1:T22 Arg2:T44	
T62	CONC 1189 1197;1212 1224	Factores de otro tipo
T63	CONC 1287 1296	evolución
#51	AnnotatorNotes T63	C0449259; Clinical course; Temporal Concept
R44	Has_Duration_or_Interval Arg1:T63 Arg2:T44	
T64	Observation 1301 1337	Participación en otro ensayo clínico
T65	PROC 1421 1430	inscritos
#52	AnnotatorNotes T65	C4041024; Enrollment in clinical trial; Research Activity
R45	Before Arg1:T65 Arg2:T48	
R46	After Arg1:T48 Arg2:T47	
T66	Quantifier_or_Qualifier 1530 1535	grave
#53	AnnotatorNotes T66	C1547227; Severe - Severity of Illness Code; Intellectual Product
R47	Has_Quantifier_or_Qualifier Arg1:T31 Arg2:T66	
T67	Result_or_Value 1565 1567	>4
R48	Has_Result_or_Value Arg1:T2 Arg2:T67	
T68	Result_or_Value 1596 1598	<5
R49	Has_Result_or_Value Arg1:T32 Arg2:T68	
T69	CONC 1602 1619	esperanza de vida
#54	AnnotatorNotes T69	C0023671; Life Expectancy; Group Attribute
R50	Has_Duration_or_Interval Arg1:T69 Arg2:T39	
T70	Quantifier_or_Qualifier 1699 1707	avanzado
#55	AnnotatorNotes T70	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
R51	Has_Quantifier_or_Qualifier Arg1:T26 Arg2:T70	
T71	CONC 592 631	inicio el momento desde su conocimiento
T72	Observation 886 923	conocerse la existencia de una lesión
R54	Before Arg1:T19 Arg2:T72	
R6	Experiences Arg1:T40 Arg2:T52	
#41	AnnotatorNotes T14	C0040044; Thrombolytic Therapy; Therapeutic or Preventive Procedure
R8	Experiences Arg1:T38 Arg2:T46	
R41	Experiences Arg1:T41 Arg2:T48	
R43	Overlap Arg1:T69 Arg2:T25	
R52	Overlap Arg1:T69 Arg2:T26	
A12	Experiencer T43 Patient
A13	Experiencer T40 Patient
A14	Experiencer T41 Patient
A15	Experiencer T34 Patient
A16	Experiencer T35 Patient
A17	Experiencer T37 Patient
A18	Experiencer T38 Patient
A19	Status T52 Future
